menu
close
Toll-Free 1-866-625-9854

Caudaline (Cilostazol)

Active Ingredient: Cilostazol
Dosage: 100 mg
Route of Administration: Oral
Dosage Form: Tablets
Quantity per package: 60 tablets per pack

Why is Cilostazol not used in the USA?

Cilostazol is used in the USA under the brand name Pletal. It is approved by the FDA and is indeed prescribed for the same indications as Caudaline. Any reference to Caudaline not being used in the USA might be due to the brand name not being marketed or recognized under this name there.

What are Similar Drugs Sold in the USA?

From the list provided, here are medications that can be used for similar vascular issues or that have antiplatelet/vasodilator properties like Cilostazol. They are grouped based on their mechanism or treatment focus:

Blood Flow Enhancers and Antiplatelets:

Vasodilators:

Cholesterol Lowering Drugs (as poor circulation is often related to atherosclerosis):

See also  Aderogyl (Vitamin A, Vitamin D, Vitamin C)

What is Caudaline?

Caudaline (also known as cilostazol) is an oral medication that is used to treat a certain blood flow problem in the legs (intermittent claudication). This condition involves pain and cramping in the lower legs due to inadequate blood flow, which is often a symptom of peripheral artery disease (PAD). Cilostazol works by helping to improve the blood flow by widening the arteries and preventing blood clots, which can improve walking distance and reduce symptoms.

Dosages

Cilostazol is typically prescribed at a dosage of 100 mg taken twice daily at least half an hour before or two hours after breakfast and dinner. The effectiveness and side effects should be evaluated regularly, and treatment should be discontinued if no improvement is seen after 3 months.

Popularity and Usage by Country

Caudaline (Cilostazol) is popular in countries where there is a higher prevalence of peripheral artery disease and lifestyle factors that contribute to poor circulation in the legs, such as Japan, South Korea, and parts of Europe. The drug’s effectiveness in treating symptoms associated with intermittent claudication makes it a preferred option in these regions.